FDA NDC Directory · JSON-LD · Markdown
NDC 49281-126 · VACCINE · INJECTION, SUSPENSION
| Generic name | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (A/MISSOURI/11/2025 PDM09-LIKE VIRUS) (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED) |
|---|---|
| Labeler / Manufacturer | Sanofi Vaccines US Inc. |
| Marketing category | Biologic License Application · App BLA103914 |
| Dosage form / route | INJECTION, SUSPENSION · INTRAMUSCULAR |
| Active ingredients | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (60 ug/.5mL) INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (60 ug/.5mL) INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED) (60 ug/.5mL) |
| Marketing started | 20260702 |
| Marketing ended | 20270630 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).